Gliclazide Mr 30 And 60 Ascend 30 mg & 60 mg MR tablets
PDF Leaflet Revision Date: 3 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
For type 2 diabetes management when diet and exercise are insufficient.
Dosage (summary)
Initial: 30 mg once daily with breakfast; may increase to 120 mg based on response.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Miconazole
- Alcohol
- Fluoroquinolones
Contraindications
- Hypersensitivity to gliclazide
- Type 1 diabetes
- Severe renal or hepatic insufficiency
- Pregnancy
- Lactation
Common side effects
- Hypoglycaemia
- Nausea
- Abdominal pain
- Rash
Counselling Points
- Monitor blood glucose regularly
- Take with meals
- Be aware of hypoglycaemia symptoms
Serious warnings
- Increased risk of cardiovascular mortality
- Risk of severe hypoglycaemia
Important Disclaimer
The Gliclazide Mr 30 And 60 Ascend 30 mg & 60 mg MR tablets professional information leaflet below is the property of Ascend Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
